Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Fish Shellfish Immunol ; 93: 934-939, 2019 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-31404633

RESUMEN

Tightened regulations and an environmentally friendly approaches in fish production have greatly reduced the use of antibiotics but green solutions are continuously being explored. The use of functional feed may have a potential in the aquaculture sector in securing biomass and minimizing the loss from disease. In the present study, we tested the concept that blood from the fish slaughterhouse can be used for mass purification of specific antibodies which subsequently can be used for feeding fish and thereby confer protection against diseases. IgM was purified from serum from Yersinia ruckeri vaccinated rainbow trout and an IgM sandwich ELISA was developed for quantification of rainbow trout IgM. The purified IgM was encapsulated in alginate microparticles and top-coated in fish feed. IgM re-extracted from the alginate microparticles was shown to retain high reactivity towards Y. ruckeri antigens indicating that its bioactivity remained intact after encapsulation. IgM release from the alginate microparticles was only observed at high pH (pH 8.2) and minimal at low pH, indicating protection of IgM at low pH in the fish stomach during passage. In a feeding - challenge experiment (feeding 1 week before Y. ruckeri challenge and for two weeks following challenge), a statistically non-significant 10% lower mortality was observed in the high dose (400 µg IgM/fish/day fed over 3 weeks) group.


Asunto(s)
Enfermedades de los Peces/inmunología , Inmunoglobulina M/metabolismo , Oncorhynchus mykiss/inmunología , Sustancias Protectoras/metabolismo , Yersiniosis/veterinaria , Yersinia ruckeri/efectos de los fármacos , Alimentación Animal/análisis , Animales , Dieta/veterinaria , Suplementos Dietéticos/análisis , Enfermedades de los Peces/tratamiento farmacológico , Inmunoglobulina M/administración & dosificación , Sustancias Protectoras/administración & dosificación , Yersiniosis/tratamiento farmacológico , Yersiniosis/inmunología
2.
PLoS One ; 11(1): e0147373, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-26824607

RESUMEN

There is an increasing demand for non-antibiotics solutions to control infectious disease in intensive pig production. Here, one such alternative, namely pig antibodies purified from slaughterhouse blood was investigated in order to elucidate its potential usability to control post-weaning diarrhoea (PWD), which is one of the top indications for antibiotics usage in the pig production. A very cost-efficient and rapid one-step expanded bed adsorption (EBA) chromatography procedure was used to purify pig immunoglobulin G from slaughterhouse pig plasma (more than 100 litres), resulting in >85% pure pig IgG (ppIgG). The ppIgG thus comprised natural pig immunoglobulins and was subsequently shown to contain activity towards four pig-relevant bacterial strains (three different types of Escherichia coli and one type of Salmonella enterica) but not towards a fish pathogen (Yersinia ruckeri), and was demonstrated to inhibit the binding of the four pig relevant bacteria to a pig intestinal cell line (IPEC-J2). Finally it was demonstrated in an in vivo weaning piglet model for intestinal colonization with an E. coli F4+ challenge strain that ppIgG given in the feed significantly reduced shedding of the challenge strain, reduced the proportion of the bacterial family Enterobacteriaceae, increased the proportion of families Enterococcoceae and Streptococcaceae and generally increased ileal microbiota diversity. Conclusively, our data support the idea that natural IgG directly purified from pig plasma and given as a feed supplement can be used in modern swine production as an efficient and cost-effective means for reducing both occurrence of PWD and antibiotics usage and with a potential for the prevention and treatment of other intestinal infectious diseases even if the causative agent might not be known.


Asunto(s)
Antibacterianos/farmacología , Diarrea/veterinaria , Suplementos Dietéticos , Infecciones por Escherichia coli/veterinaria , Inmunoglobulina G/farmacología , Enfermedades Intestinales/veterinaria , Enfermedades de los Porcinos/prevención & control , Alimentación Animal , Animales , Animales Recién Nacidos , Antibacterianos/sangre , Antibacterianos/aislamiento & purificación , Adhesión Bacteriana/efectos de los fármacos , Biodiversidad , Línea Celular , Diarrea/inmunología , Diarrea/microbiología , Diarrea/prevención & control , Células Epiteliales/efectos de los fármacos , Células Epiteliales/inmunología , Células Epiteliales/microbiología , Escherichia coli/efectos de los fármacos , Escherichia coli/crecimiento & desarrollo , Infecciones por Escherichia coli/inmunología , Infecciones por Escherichia coli/microbiología , Infecciones por Escherichia coli/prevención & control , Inmunoglobulina G/sangre , Inmunoglobulina G/aislamiento & purificación , Enfermedades Intestinales/inmunología , Enfermedades Intestinales/microbiología , Enfermedades Intestinales/prevención & control , Intestinos/efectos de los fármacos , Intestinos/inmunología , Intestinos/microbiología , Pruebas de Sensibilidad Microbiana , Microbiota/efectos de los fármacos , Salmonella enterica/efectos de los fármacos , Salmonella enterica/crecimiento & desarrollo , Porcinos , Enfermedades de los Porcinos/inmunología , Enfermedades de los Porcinos/microbiología , Destete , Yersinia ruckeri/crecimiento & desarrollo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...